SPHK1 and Alzheimer disease: Since sphingosine kinase 1 is reduced in human AD neurons (Lee et al., 2018) and several SPMs are diminished in cerebrospinal fluid from patients with AD (Nielsen et al., 2016; Zhu et al., 2016), this study provides a new framework for targeting resolution and SPM to dampen inflammation in AD.